Genetic Susceptibility to Bladder Cancer Risk and Outcome

• Jemal A , SiegelR, XuJ, WardE: Cancer statistics, 2010.CA Cancer J. Clin.60(5) , 277–300 (2010).
   PubMed Web of Science ®Google Scholar
• Wu X , RosMM, GuJ, KiemeneyL: Epidemiology and genetic susceptibility to bladder cancer.BJU Int.102(9 Pt B) , 1207–1215 (2008).
   PubMed Web of Science ®Google Scholar
• Zeegers MP , TanFE, DorantE, van Den Brandt PA: The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer89(3) , 630–639 (2000).
   PubMed Web of Science ®Google Scholar
• Reulen RC , KellenE, BuntinxF, BrinkmanM, ZeegersMP: A meta-analysis on the association between bladder cancer and occupation.Scand. J. Urol. Nephrol. Suppl. (218), 64–78 (2008).
   PubMedGoogle Scholar
• Villanueva CM , CantorKP, CordierS et al.: Disinfection byproducts and bladder cancer: a pooled analysis.Epidemiology15(3) , 357–367 (2004).
   PubMed Web of Science ®Google Scholar
• Villanueva CM , CantorKP, KingWD et al.: Total and specific fluid consumption as determinants of bladder cancer risk.Int. J. Cancer118(8) , 2040–2047 (2006).
   PubMed Web of Science ®Google Scholar
• Chen CJ , ChuangYC, YouSL, LinTM, WuHY: A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan.Br. J. Cancer53(3) , 399–405 (1986).
   PubMed Web of Science ®Google Scholar
• Aben KK , WitjesJA, SchoenbergMP et al.: Familial aggregation of urothelial cell carcinoma.Int. J. Cancer98(2) , 274–278 (2002).
   PubMed Web of Science ®Google Scholar
• Kramer AA , GrahamS, BurnettWS, NascaP: Familial aggregation of bladder cancer stratified by smoking status.Epidemiology2(2) , 145–148 (1991).
   PubMedGoogle Scholar
• Lichtenstein P , HolmNV, VerkasaloPK et al.: Environmental and heritable factors in the causation of cancer – analyses of cohorts of twins from Sweden, Denmark, and Finland.N. Engl. J. Med.343(2) , 78–85 (2000).
   PubMed Web of Science ®Google Scholar
• Aben KK , BagliettoL, Baffoe-BonnieA et al.: Segregation analysis of urothelial cell carcinoma.Eur. J. Cancer42(10) , 1428–1433 (2006).
   PubMed Web of Science ®Google Scholar
• Garcia-Closas M , MalatsN, SilvermanD et al.: NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.Lancet366(9486) , 649–659 (2005).
   PubMed Web of Science ®Google Scholar
• Gu J , LiangD, WangY, LuC, WuX: Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians.Mutat. Res.581(1–2) , 97–104 (2005).
   PubMed Web of Science ®Google Scholar
• Stern MC , LinJ, FigueroaJD et al.: Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer.Cancer Res.69(17) , 6857–6864 (2009).
   PubMed Web of Science ®Google Scholar
• Kiemeney LA , ThorlaciusS, SulemP et al.: Sequence variant on 8q24 confers susceptibility to urinary bladder cancer.Nat. Genet.40(11) , 1307–1312 (2008).
   PubMed Web of Science ®Google Scholar
• Wu X , YeY, KiemeneyLA et al.: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer.Nat. Genet.41(9) , 991–995 (2009).
   PubMed Web of Science ®Google Scholar
• Kiemeney LA , SulemP, BesenbacherS et al.: A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.Nat. Genet.42(5) , 415–419 (2010).
   PubMed Web of Science ®Google Scholar
• Rafnar T , SulemP, StaceySN et al.: Sequence variants at the TERT–CLPTM1L locus associate with many cancer types.Nat. Genet.41(2) , 221–227 (2009).
   PubMed Web of Science ®Google Scholar
• Rothman N , Garcia-ClosasM, ChatterjeeN et al.: A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.Nat. Genet.42(11) , 978–984 (2010).
   PubMed Web of Science ®Google Scholar
• Grotenhuis AJ , VermeulenSH, KiemeneyLA: Germline genetic markers for urinary bladder cancer risk, prognosis and treatment response.Future Oncol.6(9) , 1433–1460 (2010).
   PubMed Web of Science ®Google Scholar
• Wu X , LinX, DinneyCP, GuJ, GrossmanHB: Genetic polymorphism in bladder cancer.Front Biosci.12 , 192–213 (2007).
   PubMed Web of Science ®Google Scholar
• Horikawa Y , GuJ, WuX: Genetic susceptibility to bladder cancer with an emphasis on gene–gene and gene–environmental interactions.Curr. Opin. Urol.18(5) , 493–498 (2008).
   PubMed Web of Science ®Google Scholar
• Malats N : Genetic epidemiology of bladder cancer: scaling up in the identification of low-penetrance genetic markers of bladder cancer risk and progression.Scand. J. Urol. Nephrol. Suppl. (218), 131–140 (2008).
   PubMedGoogle Scholar
• Vatsis KP , WeberWW, BellDA et al.: Nomenclature for N-acetyltransferases.Pharmacogenetics5(1) , 1–17 (1995).
   PubMedGoogle Scholar
• Hein DW : Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis.Mutat. Res.506–507 , 65–77 (2002).
   PubMed Web of Science ®Google Scholar
• Agundez JA : Polymorphisms of human N-acetyltransferases and cancer risk.Curr. Drug Metab.9(6) , 520–531 (2008).
   PubMed Web of Science ®Google Scholar
• Dong LM , PotterJD, WhiteE, UlrichCM, CardonLR, PetersU: Genetic susceptibility to cancer: the role of polymorphisms in candidate genes.JAMA299(20) , 2423–2436 (2008).
   PubMed Web of Science ®Google Scholar
• Yeager M , ChatterjeeN, CiampaJ et al.: Identification of a new prostate cancer susceptibility locus on chromosome 8q24.Nat. Genet.41(10) , 1055–1057 (2009).
   PubMed Web of Science ®Google Scholar
• Chung CC , MagalhaesWC, Gonzalez-BosquetJ, ChanockSJ: Genome-wide association studies in cancer – current and future directions.Carcinogenesis31(1) , 111–120 (2010).
   PubMed Web of Science ®Google Scholar
• Ghoussaini M , SongH, KoesslerT et al.: Multiple loci with different cancer specificities within the 8q24 gene desert.J. Natl Cancer Inst.100(13) , 962–966 (2008).
   PubMedGoogle Scholar
• Eeles RA , Kote-JaraiZ, Al Olama AA et al.: Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat. Genet.41(10) , 1116–1121 (2009).
   PubMed Web of Science ®Google Scholar
• Crowther-Swanepoel D , BroderickP, Di Bernardo MC et al.: Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk. Nat. Genet.42(2) , 132–136 (2010).
   PubMed Web of Science ®Google Scholar
• Tomlinson IP , WebbE, Carvajal-CarmonaL et al.: A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3.Nat. Genet.40(5) , 623–630 (2008).
   PubMed Web of Science ®Google Scholar
• Easton DF , PooleyKA, DunningAM et al.: Genome-wide association study identifies novel breast cancer susceptibility loci.Nature447(7148) , 1087–1093 (2007).
   PubMed Web of Science ®Google Scholar
• Zanke BW , GreenwoodCM, RangrejJ et al.: Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24.Nat. Genet.39(8) , 989–994 (2007).
   PubMed Web of Science ®Google Scholar
• Yeager M , OrrN, HayesRB et al.: Genome-wide association study of prostate cancer identifies a second risk locus at 8q24.Nat. Genet.39(5) , 645–649 (2007).
   PubMed Web of Science ®Google Scholar
• Wu X , HildebrandtMA, ChangDW: Genome-wide association studies of bladder cancer risk: a field synopsis of progress and potential applications.Cancer Metastasis Rev.28(3–4) , 269–280 (2009).
   PubMed Web of Science ®Google Scholar
• Cortessis VK , YuanJM, Van Den Berg D et al.: Risk of urinary bladder cancer is associated with 8q24 variant rs9642880[T] in multiple racial/ethnic groups: results from the Los Angeles–Shanghai case–control study. Cancer Epidemiol. Biomarkers Prev.19(12) , 3150–3156 (2010).
   PubMed Web of Science ®Google Scholar
• Wang M , ZhangW, YuanL, FuG, WeiQ, ZhangZ: Common genetic variants on 8q24 contribute to susceptibility to bladder cancer in a Chinese population.Carcinogenesis30(6) , 991–996 (2009).
   PubMed Web of Science ®Google Scholar
• Ahmadiyeh N , PomerantzMM, GrisanzioC et al.: 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC.Proc. Natl Acad. Sci. USA107(21) , 9742–9746 (2010).
   PubMed Web of Science ®Google Scholar
• Pomerantz MM , AhmadiyehN, JiaL et al.: The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer.Nat. Genet.41(8) , 882–884 (2009).
   PubMed Web of Science ®Google Scholar
• Sotelo J , EspositoD, DuhagonMA et al.: Long-range enhancers on 8q24 regulate c-Myc.Proc. Natl Acad. Sci. USA107(7) , 3001–3005 (2010).
   PubMed Web of Science ®Google Scholar
• Wasserman NF , AneasI, NobregaMA: An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer.Genome Res.20(9) , 1191–1197 (2010).
   PubMed Web of Science ®Google Scholar
• Lehmann ML , SelinskiS, BlaszkewiczM et al.: Rs710521[A] on chromosome 3q28 close to TP63 is associated with increased urinary bladder cancer risk.Arch. Toxicol.84(12) , 967–978 (2010).
   PubMed Web of Science ®Google Scholar
• Stern MC , Van Den Berg D, Yuan JM et al.: Sequence variant on 3q28 and urinary bladder cancer risk: findings from the Los Angeles–Shanghai bladder case–control study. Cancer Epidemiol. Biomarkers Prev.18(11) , 3057–3061 (2009).
   PubMed Web of Science ®Google Scholar
• Comperat E , BiecheI, DargereD et al.: p63 gene expression study and early bladder carcinogenesis.Urology70(3) , 459–462 (2007).
   PubMed Web of Science ®Google Scholar
• Urist MJ , Di Como CJ, Lu ML et al.: Loss of p63 expression is associated with tumor progression in bladder cancer. Am. J. Pathol.161(4) , 1199–1206 (2002).
   PubMed Web of Science ®Google Scholar
• Zigeuner R , TsybrovskyyO, RatschekM, RehakP, LipskyK, LangnerC: Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.Urology63(6) , 1079–1083 (2004).
   PubMed Web of Science ®Google Scholar
• Wang S , TangJ, WangM, YuanL, ZhangZ: Genetic variation in PSCA and bladder cancer susceptibility in a Chinese population.Carcinogenesis31(4) , 621–624 (2010).
   PubMed Web of Science ®Google Scholar
• Amara N , PalapattuGS, SchrageM et al.: Prostate stem cell antigen is overexpressed in human transitional cell carcinoma.Cancer Res.61(12) , 4660–4665 (2001).
   PubMed Web of Science ®Google Scholar
• Elsamman E , FukumoriT, KasaiT et al.: Prostate stem cell antigen predicts tumour recurrence in superficial transitional cell carcinoma of the urinary bladder.BJU Int.97(6) , 1202–1207 (2006).
   PubMed Web of Science ®Google Scholar
• Sakamoto H , YoshimuraK, SaekiN et al.: Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer.Nat. Genet.40(6) , 730–740 (2008).
   PubMed Web of Science ®Google Scholar
• Bahrenberg G , BrauersA, JoostHG, JakseG: Reduced expression of PSCA, a member of the LY-6 family of cell surface antigens, in bladder, esophagus, and stomach tumors.Biochem. Biophys. Res. Commun.275(3) , 783–788 (2000).
   PubMed Web of Science ®Google Scholar
• Reiter RE , GuZ, WatabeT et al.: Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer.Proc. Natl Acad. Sci. USA95(4) , 1735–1740 (1998).
   PubMed Web of Science ®Google Scholar
• Pandith AA , ShahZA, SiddiqiMA: Oncogenic role of fibroblast growth factor receptor 3 in tumorigenesis of urinary bladder cancer.Urol. Oncol. (2010) (Epub ahead of print).
   Google Scholar
• Baird DM : Variation at the TERT locus and predisposition for cancer.Expert Rev. Mol. Med.12 , e16 (2010).
   PubMed Web of Science ®Google Scholar
• Petersen GM , AmundadottirL, FuchsCS et al.: A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33.Nat. Genet.42(3) , 224–228 (2010).
   PubMed Web of Science ®Google Scholar
• Shete S , HoskingFJ, RobertsonLB et al.: Genome-wide association study identifies five susceptibility loci for glioma.Nat. Genet.41(8) , 899–904 (2009).
   PubMed Web of Science ®Google Scholar
• Stacey SN , SulemP, MassonG et al.: New common variants affecting susceptibility to basal cell carcinoma.Nat. Genet.41(8) , 909–914 (2009).
   PubMed Web of Science ®Google Scholar
• Wang Y , BroderickP, WebbE et al.: Common 5p15.33 and 6p21.33 variants influence lung cancer risk.Nat. Genet.40(12) , 1407–1409 (2008).
   PubMed Web of Science ®Google Scholar
• Pooley KA , TyrerJ, ShahM et al.: No association between TERT–CLPTM1L single nucleotide polymorphism rs401681 and mean telomere length or cancer risk.Cancer Epidemiol. Biomarkers Prev.19(7) , 1862–1865 (2010).
   PubMed Web of Science ®Google Scholar
• Schraml P , BucherC, BissigH et al.: Cyclin E overexpression and amplification in human tumours.J. Pathol.200(3) , 375–382 (2003).
   PubMed Web of Science ®Google Scholar
• Mackenzie PI , OwensIS, BurchellB et al.: The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence.Pharmacogenetics7(4) , 255–269 (1997).
   PubMedGoogle Scholar
• Perera MA , InnocentiF, RatainMJ: Pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 polymorphisms: are we there yet?Pharmacotherapy28(6) , 755–768 (2008).
   PubMed Web of Science ®Google Scholar
• Giuliani L , GazzanigaP, CaporuscioF, CiottiM, FratiL, AglianoAM: Can down-regulation of UDP-glucuronosyltransferases in the urinary bladder tissue impact the risk of chemical carcinogenesis?Int. J. Cancer91(1) , 141–143 (2001).
   PubMed Web of Science ®Google Scholar
• Iida K , MimuraJ, ItohK et al.: Suppression of AhR signaling pathway is associated with the down-regulation of UDP-glucuronosyltransferases during BBN-induced urinary bladder carcinogenesis in mice.J. Biochem.147(3) , 353–360 (2010).
   PubMed Web of Science ®Google Scholar
• Dinney CP , McConkeyDJ, MillikanRE et al.: Focus on bladder cancer.Cancer Cell6(2) , 111–116 (2004).
   PubMed Web of Science ®Google Scholar
• Bakkar AA , WallerandH, RadvanyiF et al.: FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder.Cancer Res.63(23) , 8108–8112 (2003).
   PubMed Web of Science ®Google Scholar
• Kurth K , DenisL, SylvesterR, de Pauw M: The natural history and the prognosis of treated superficial bladder cancer. EORTC GU Group. Prog. Clin. Biol. Res.378 , 1–7 (1992).
   PubMedGoogle Scholar
• Pashos CL , BottemanMF, LaskinBL, RedaelliA: Bladder cancer: epidemiology, diagnosis, and management.Cancer Pract.10(6) , 311–322 (2002).
   PubMedGoogle Scholar
• Smith JA Jr, Labasky RF, Cockett AT, Fracchia JA, Montie JE, Rowland RG: Bladder cancer clinical guidelines panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and TIS). The American Urological Association. J. Urol.162(5) , 1697–1701 (1999).
   PubMed Web of Science ®Google Scholar
• Gontero P , BohleA, MalmstromPU et al.: The role of bacillus Calmette–Guerin in the treatment of non-muscle-invasive bladder cancer.Eur. Urol.57(3) , 410–429 (2010).
   PubMed Web of Science ®Google Scholar
• Williams SK , HoenigDM, GhavamianR, SolowayM: Intravesical therapy for bladder cancer.Expert Opin. Pharmacother.11(6) , 947–958 (2010).
   PubMed Web of Science ®Google Scholar
• Merz VW , MarthD, KraftR, AckermannDK, ZinggEJ, StuderUE: Analysis of early failures after intravesical instillation therapy with bacille Calmette–Guerin for carcinoma in situ of the bladder.Br. J. Urol.75(2) , 180–184 (1995).
   PubMedGoogle Scholar
• Schenk-Braat EA , BangmaCH: Immunotherapy for superficial bladder cancer.Cancer Immunol. Immunother.54(5) , 414–423 (2005).
   PubMed Web of Science ®Google Scholar
• Stein JP , LieskovskyG, CoteR et al.: Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.J. Clin. Oncol.19(3) , 666–675 (2001).
   PubMed Web of Science ®Google Scholar
• Advanced Bladder Cancer Meta-analysis Collaboration: Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis. Lancet361(9373) , 1927–1934 (2003).
   PubMed Web of Science ®Google Scholar
• Millikan R , Siefker-RadtkeA, GrossmanHB: Neoadjuvant chemotherapy for bladder cancer.Urol. Oncol.21(6) , 464–467 (2003).
   PubMed Web of Science ®Google Scholar
• Grossman HB , DinneyCP: If cystectomy is insufficient, what is an urologist to do?Urol. Oncol.21(6) , 475–478 (2003).
   PubMed Web of Science ®Google Scholar
• Luo Y , ChenX, O‘DonnellMA: Role of Th1 and Th2 cytokines in BCG-induced IFN-γ production: cytokine promotion and simulation of BCG effect.Cytokine21(1) , 17–26 (2003).
   PubMed Web of Science ®Google Scholar
• Saint F , PatardJJ, MailleP et al.: T helper 1/2 lymphocyte urinary cytokine profiles in responding and nonresponding patients after 1 and 2 courses of bacillus Calmette–Guerin for superficial bladder cancer.J. Urol.166(6) , 2142–2147 (2001).
   PubMed Web of Science ®Google Scholar
• Leibovici D , GrossmanHB, DinneyCP et al.: Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival.J. Clin. Oncol.23(24) , 5746–5756 (2005).
   PubMed Web of Science ®Google Scholar
• Chen M , HildebrandtMA, ClagueJ et al.: Genetic variations in the sonic hedgehog pathway affect clinical outcomes in non-muscle-invasive bladder cancer.Cancer Prev. Res.3(10) , 1235–1245 (2010).
   PubMed Web of Science ®Google Scholar
• Sakano S , WadaT, MatsumotoH et al.: Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy.Br. J. Cancer95(5) , 561–570 (2006).
   PubMed Web of Science ®Google Scholar
• Daly AK : Genome-wide association studies in pharmacogenomics.Nat. Rev. Genet.11(4) , 241–246 (2010).
   PubMed Web of Science ®Google Scholar
• Penney KL , PyneS, SchumacherFR et al.: Genome-wide association study of prostate cancer mortality.Cancer Epidemiol. Biomarkers Prev.19(11) , 2869–2876 (2010).
   PubMed Web of Science ®Google Scholar
• Huang YT , HeistRS, ChirieacLR et al.: Genome-wide analysis of survival in early-stage non-small-cell lung cancer.J. Clin. Oncol.27(16) , 2660–2667 (2009).
   PubMed Web of Science ®Google Scholar
• Azzato EM , PharoahPD, HarringtonP et al.: A genome-wide association study of prognosis in breast cancer.Cancer Epidemiol. Biomarkers Prev.19(4) , 1140–1143 (2010).
   PubMed Web of Science ®Google Scholar
• Park JH , WacholderS, GailMH et al.: Estimation of effect size distribution from genome-wide association studies and implications for future discoveries.Nat. Genet.42(7) , 570–575 (2010).
   PubMed Web of Science ®Google Scholar
• Wu X , LinJ, GrossmanHB et al.: Projecting individualized probabilities of developing bladder cancer in white individuals.J. Clin. Oncol.25(31) , 4974–4981 (2007).
   PubMed Web of Science ®Google Scholar
• Lin J , KadlubarFF, SpitzMR, ZhaoH, WuX: A modified host cell reactivation assay to measure DNA repair capacity for removing 4-aminobiphenyl adducts: a pilot study of bladder cancer.Cancer Epidemiol. Biomarkers Prev.14(7) , 1832–1836 (2005).
   PubMed Web of Science ®Google Scholar
• McGrath M , WongJY, MichaudD, HunterDJ, De Vivo I: Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol. Biomarkers Prev.16(4) , 815–819 (2007).
   PubMed Web of Science ®Google Scholar
• Wu X , AmosCI, ZhuY et al.: Telomere dysfunction: a potential cancer predisposition factor.J. Natl Cancer Inst.95(16) , 1211–1218 (2003).
   PubMedGoogle Scholar
• Willeit P , WilleitJ, MayrA et al.: Telomere length and risk of incident cancer and cancer mortality.JAMA304(1) , 69–75 (2010).
   PubMed Web of Science ®Google Scholar

▪ ;Website

• Hindorff LA, Junkins HA, Hall PN, Mehta JP, Manolio TA: A catalog of published genome-wide association studies www.genome.gov/gwastudies
   Google Scholar